Eliem Therapeutics Quote - ELYM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

5.11

Bid

4.90

Offer

5.30

Volume

0.00 Day's Range 0.00

2.35 52 Week Range 11.55

Market Cap

342.677M

Previous Close

5.11

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

404,937

Shares Outstanding

67,060,163

Dividend Yield

PE Ratio

-9.76

Earnings Per Share (EPS)

-0.52

Revenue

Net Profit

-35.12M

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

climbbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Eliem Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELYM. The last closing price for Eliem Therapeutics was US$5.11. Over the last year, Eliem Therapeutics shares have traded in a share price range of US$ 2.35 to US$ 11.55.

Eliem Therapeutics currently has 67,060,163 shares in issue. The market capitalisation of Eliem Therapeutics is US$342.68 million. Eliem Therapeutics has a price to earnings ratio (PE ratio) of -9.76.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	5.11	5.11	5.11	0	0	CS
4	0	0	5.11	5.11	5.11	0	0	CS
12	-0.66	-11.43847487	5.77	8.79	4.7521	404937	6.70140656	CS
26	-3.48	-40.5122235157	8.59	9.58	4.7521	278800	6.97168205	CS
52	2.545	99.2202729045	2.565	11.55	2.35	359424	5.8133055	CS
156	-12.89	-71.6111111111	18	19.6	2.21	153365	5.62023822	CS
260	-11.14	-68.5538461538	16.25	29.69	2.21	155368	6.93843443	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M